VIDEO: What’s new with perioperative anti-inflammatories in cataract surgery

NEW YORK — In his presentation at OSN New York 2019, John A. Hovanesian, MD, FACS, of Harvard Eye Associates in Laguna Hills, California, discusses new steroid delivery options such as Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) and Dexycu (dexamethasone intraocular suspension 9%, EyePoint Pharmaceuticals), as well as other new steroids and NSAIDs in cataract surgery. – by David W. Mullin

Full Story →